Lupin Pharmaceuticals Inc. is recalling 52,128 bottles of Sertraline Hydrochloride Tablets USP (100 mg), commonly known as Zoloft. The recall was initiated because the container seal is not properly adhering to the bottles, which could compromise the integrity of the medication. Each recalled bottle contains 90 tablets and was distributed nationwide.
A defective seal may allow air or moisture to enter the bottle, potentially reducing the effectiveness of the medication or leading to contamination. This is particularly concerning for patients relying on consistent dosing for mental health conditions.
You have 2 options:
Rx Only; Manufactured by Lupin Pharmaceuticals, Inc., Naples, FL 34108
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.